Director, W.M. Keck Center for Collaborative Neuroscience
Wise Young is recognized as one of the world's outstanding neuroscientists. In 1990 he was on the team that discovered high-dose methylprednisolone (MP) as the first effective therapy for spinal cord injuries, upending the idea that spinal cord injuries were permanent. This team also was instrumental in Andy Blight's signal work on 4-aminopyridine (4-AP), which shows significant promise to increase nerve conductivity.
Dr. Young received his medical degree from Stanford University. After a surgery internship at New York University Medical Center, he joined the neurosurgery department at NYU. In 1997 Rutgers asked him to design and direct the research program he now heads.
To promote spinal injury and brain research, Dr. Young founded the Journal of Neurotrauma and organized the Neurotrauma Society and the International Neurotrauma Society. He has served on advisory committees for the NIH, the National Academy of Sciences, NICHD, and other spinal cord injury organizations.
He has appeared on many television programs, including "20/20" with Barbara Walters and Christopher Reeve and CNN's news magazine with Jeff Greenfield. His work has been featured in Life Magazine, USA Today, and elsewhere. His honors include the NIH Jacob Javits Neuroscience Award (1985-1992), the Wakeman Award (1991), the "Cure" Award (1998), and the Trustees Award for Excellence in Research (2001). Last year, TIME Magazine named him "America's Best" in the field of spinal cord injury research.
Dr. Young is a graduate of Reed College and also holds a doctorate from the University of Iowa.